By Memorandum Opinion entered by The Honorable Colm F. Connolly in Pharmacyclics LLC et al. v. Alvogen Pine Brook LLC et al., Civil Action No. 19-0434-CFC-CJB (D.Del. August 19,
Continue Reading Chief Judge Connolly Issues Comprehensive Opinion Setting Forth Court’s Findings of Fact and Conclusions of Law on Infringement Claims and Invalidity Defenses as to Patents-in-Suit Following ANDA Trial

By Memorandum Opinion entered in Allergan USA, Inc. et al. v. Aurobindo Pharma Ltd., et al., Civil Action No. 19-1727-RGA (D.Del. January 11, 2021), The Honorable Richard G. Andrews construed
Continue Reading Judge Andrews Issues Markman Opinion Construing Five Remaining Terms in Dispute in Six Patents-in-Suit in Hatch-Waxman Action

By Opinion entered by The Honorable Leonard P. Stark in Bristol-Myers Squibb Co. et al v. Aurobindo Pharma USA Inc. et al., Civil Action No. 17-374-LPS (D.Del. August 5,
Continue Reading Following ANDA Trial, Chief Judge Stark Finds Remaining Defendants’ Proposed Drug Products Infringe Asserted Claims of Patents-in-Suit Connected to Plaintiffs’ Eliquis® Product

By Opinion entered by The Honorable Leonard P. Stark in Belcher Pharmaceutical, LLC v. Hospira, Inc., Civil Action No. 17-775-LPS (D.Del. March 31, 2020), following a two day bench
Continue Reading Chief Judge Stark Finds that Defendant Hospira Does Not Infringe Plaintiff Belcher’s Patent-in-Suit and Patent is Invalid and Unenforceable

By Memorandum Order entered by The Honorable Gregory M. Sleet in Amgen Inc. v. Macleods Pharmaceuticals, Ltd., Civil Action No. 17-817-GMS (D.Del. December 19, 2017) (consolidated), the Court denied
Continue Reading Judge Sleet Denies Macleods Defendants’ Motion for Judgment on the Pleadings in ANDA Action

By Memorandum Order entered by The Honorable Leonard P. Stark in Reckitt Benckiser LLC v. Aurobindo Pharma Limited et al., Civil Action No. 14-1203-LP (D.Del. October 16, 2017), the
Continue Reading Chief Judge Stark Denies Prevailing Party’s Motion for Attorneys’ Fees and Expenses in ANDA Action

Following a three-day bench trial in the matter on June 5-7, 2017 and after having considered the entire record in the case and the applicable law, the Court, through Trial
Continue Reading Judge Andrews Finds Plaintiff Proved Infringement of Asserted Claims of Patents-in-Suit Following Three-Day Bench Trial in Hatch-Waxman Action

Following a five-day bench trial in the matter in February 2017 and after having considered the entire record in the case and the applicable law, the Court, through Memorandum, entered
Continue Reading Judge Sleet Invalidates Patents-in-Suit After Finding of Obviousness and Enters Judgment in Favor of Alleged Infringer in Hatch-Waxman Action

By Memorandum Order entered by The Honorable Leonard P. Stark in UCB, Inc., et al. v. Watson Laboratories, Inc. et al., Civil Action No. 14-1083-LPS-SRF (D.Del., May 19, 2017),
Continue Reading Chief Judge Stark Denies Defendants’ Motion for Reargument of Court’s Order Holding Defendants Liable for Costs of ANDA Litigation Going Forward Under Certain Conditions

By Memorandum Opinion entered by The Honorable Leonard P. Stark in Reckitt Benckiser LLC v. Aurobindo Pharma Ltd., Civil Action No. 14-1203-LPS (D.Del. March 6, 2017), the Court granted
Continue Reading Chief Judge Stark Grants Defendants’ Motion for Summary Judgment of Non-Infringement in ANDA Action